Olema Pharmaceuticals (OLMA) PT Raised to $58 at JPMorgan

March 18, 2026 8:22 AM

JPMorgan analyst Anupam Rama raised the price target on Olema Pharmaceuticals (NASDAQ: OLMA) to $58.00 (from $55.00) while maintaining a Overweight rating.

No results found